drugset

drugset / Trial / NCT05670457

Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

NCT05670457 ↗

Phase 3 Unknown 44 enrolled Tanta University

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the safety and efficacy of diosmin as adjuvant therapy in treatment of non-bleeding peptic ulcer patients.

Timeline

Start: 2022-06-30
Primary completion: 2024-06
Completion: 2025-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Diosmin	Small molecule	500 mg	—

Indications